Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactions

Cited by (359)

Items 201–300 of 359

1. Towards a CRISPeR understanding of homologous recombination with high-throughput functional genomics
   Samuel B. Hayward, Alberto Ciccia · 2021 · Current Opinion in Genetics & Development
2. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens
   Mina Karimpour, Mehdi Totonchi, Mehrdad Behmanesh, Hesam Montazeri · 2023 · Life Science Alliance
3. Identification of β‑catenin target genes in colorectal cancer by interrogating gene fitness screening data
   Haomin Zhao, Liang He, Dexin Yin, Bin Song · 2019 · Oncology Letters
4. Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures
   Michael Y. Hu, Xin Yi Lei, Jon D. Larson, Melissa McAlonis‐Downes, Kyle M. Ford, Daniella McDonald, Krystal Mach, Jessica M. Rusert, Robert J. Wechsler‐Reya, Prashant Mali · 2021 · Biomaterials
5. Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer
   Sarah J. Backe, Rebecca Sager, Katherine A. Meluni, Mark R. Woodford, Dimitra Bourboulia, Mehdi Mollapour · 2022 · Biomolecules
6. Synthetic Lethality in Drug Development: The Dawn is Coming
   Shuaishi Gao, Luhua Lai · 2018 · Future Medicinal Chemistry
7. Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.
   Magdalena Markowska, Magdalena A. Budzinska, Anna M. L. Coenen-Stass, Senbai Kang, Ewa Kizling, Krzysztof Kolmus, Krzysztof Koras, Eike Staub, Ewa Szczurek · 2023 · Scientific Reports
8. CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges
   Duy Anh Hoang Nguyen, Minh Trong Quang · 2025 · Molecular Biotechnology
9. Exploring a Local Genetic Interaction Network Using Evolutionary Replay Experiments
   Ryan C. Vignogna, Sean W. Buskirk, Gregory I. Lang · 2021 · Molecular Biology and Evolution
10. CRISPR-based genetic interaction maps inform therapeutic strategies in cancer
    Poornima Ramkumar, Martin Kampmann · 2018 · Translational Cancer Research
11. Efficient gene knockout and genetic interactions: the IN4MER CRISPR/Cas12a multiplex knockout platform
    Nazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma, Lori Wilson, Ryan Steger, Annabel K. Sangree, Medina Colic, Sidney H. Wang, John G. Doench, Traver Hart · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
12. Elucidating the genetic mechanisms governing cytosine base editing outcomes through CRISPRi screens
    Sifeng Gu, Zsolt Bodai, Rachel A. Anderson, Hei Yu Annika So, Quinn T. Cowan, Alexis C. Komor · 2025 · Nature Communications
13. Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope.
    Yuqi Wu, Ya-Li Wang, Yanbin Wang, Hong Qiu, Xiang-Lin Yuan, Hua Xiong, Yan-Mei Zou · 2025 · Biochimica et biophysica acta. Reviews on cancer
14. Global genetic interaction network of a human cell maps conserved principles and informs functional interpretation of gene co-essentiality profiles
    Maximilian Billmann, Michael Costanzo, Xiang Zhang, Arshia Zernab Hassan, Mahfuzur Rahman, Kevin R. Brown, Katherine S. Chan, Amy H.Y. Tong, Carles Pons, Henry N. Ward et al. · 2026 · Cell
15. Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
    Kerui Huang, Jianhong Tian, Wenyan Zhao, Siqin Zhang, Lixuan Xiang, Meiqing Yang, Liu Ls, Y Huang, Ningyun Zhang, Lei Sun et al. · 2026 · iMetaOmics.
16. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma
    Li Guo, Yaodong Zhang, Zibo Yin, Yaya Ji, Guowei Yang, Bowen Qian, Sunjing Li, Jun Wang, Tingming Liang, Changxian Li et al. · 2020 · Aging
17. Functional buffering via cell-specific gene expression promotes tissue homeostasis and cancer robustness
    Hao-Kuen Lin, Jen‐Hao Cheng, Chia‐Chou Wu, Feng‐Shu Hsieh, Carolyn A Dunlap, Sheng‐hong Chen · 2022 · Scientific Reports
18. Correcting CRISPR for copy number
    John Paul Shen, Trey E. Ideker · 2017 · Nature Genetics
19. Coessentiality and cofunctionality: a network approach to learning genetic vulnerabilities from cancer cell line fitness screens
    Traver Hart, Clara WT Koh, Jason Moffat · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
20. Comprehensive synergy mapping links a BAF- and NSL-containing “supercomplex” to the transcriptional silencing of HIV-1
    Zichong Li, Steven G. Deeks, Mélanie Ott, Warner C. Greene · 2023 · Cell Reports
21. CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic Potential in Cancers
    Yuna Kim, Hyeong-Min Lee · 2023 · Cells
22. Hepatic organoids move from adolescence to maturity
    Yuan Guan, Gary Peltz · 2024 · Liver International
23. Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
    Tackhoon Kim, Byung-Sun Park, Soobeen Heo, Heeju Jeon, Jaeyeal Kim, Donghwa Kim, Sang Kook Lee, So‐Youn Jung, Sun‐Young Kong, Timothy K. Lu · 2024 · eLife
24. Edited course of biomedical research: leaping forward with CRISPR
    Patrick J. Collins, Christopher M. Hale, Han Xu · 2017 · Pharmacological Research
25. Construction of a CRISPR‐based paired‐sgRNA library for chromosomal deletion of long non‐coding RNAs
    Minzhen Tao, Qiaochu Mu, Yurui Zhang, Zhen Xie · 2020 · Quantitative Biology
26. An in-library ligation strategy and its application in CRISPR/Cas9 screening of high-order gRNA combinations
    Zhike Lu, Ke Ni, Yingying Wang, Yangfan Zhou, Yini Li, Jianfeng Yan, Qingkai Song, Min Liu, Yujun Xu, Zhenxing Yu et al. · 2022 · Nucleic Acids Research
27. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference
    Yuyang Dou, Yujie Ren, Xinmiao Zhao, Jiaming Jin, Shizheng Xiong, Lulu Luo, Xinru Xu, Xueni Yang, Jiafeng Yu, Li Guo et al. · 2024 · Computers in Biology and Medicine
28. Target Discovery for Precision Medicine Using High-Throughput Genome Engineering
    Xinyi Guo, Poonam Chitale, Neville E. Sanjana · 2017 · Advances in experimental medicine and biology
29. From parts to mechanisms: research heuristics for addressing heterogeneity in cancer genetics
    William Bechtel · 2019 · History & Philosophy of the Life Sciences
30. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
    Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan, Lynn E. Heasley · 2019 · Molecular Pharmacology
31. Computational Methods for Analysis of Large-Scale CRISPR Screens
    Xueqiu Lin, Augustine G. Chemparathy, Marie F. La Russa, Timothy Daley, Lei S. Qi · 2020 · Annual Review of Biomedical Data Science
32. ASTER: A Method to Predict Clinically Actionable Synthetic Lethal Genetic Interactions
    Herty Liany, Anand Devaprasath D. Jeyasekharan, Vaibhav Rajan · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
33. A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screening
    Victoria J. Harle, Victoria Offord, Birkan Gökbağ, Lazaros Fotopoulos, Thomas Williams, Diana Alexander, Ishan Mehta, Nicola Thompson, Rebeca Olvera-León, Stefan Peidli et al. · 2025 · Genome biology
34. eys; lrp5 Zebrafish Reveals Lrp5 Can Be the Receptor of Retinol in the Visual Cycle
    Shimpei Takita, Yuko Seko · 2020 · iScience
35. In situ detection of protein interactions for recombinant therapeutic enzymes
    Mojtaba Samoudi, Chih‐Chung Kuo, Caressa M. Robinson, Km Shams‐Ud‐Doha, Song‐Min Schinn, Stefan Kol, Linus Weiß, Sara Petersen Bjørn, Bjørn Gunnar Rude Voldborg, Alexandre Rosa Campos et al. · 2020 · Biotechnology and Bioengineering
36. Comparative Analysis of CRISPR-Cas Systems in Vibrio and Photobacterium Genomes of High Influence in Aquaculture Production
    2020 · Biointerface Research in Applied Chemistry
37. Optimized metrics for orthogonal combinatorial CRISPR screens
    Ronay Çetin, Martin Wegner, Leah Luwisch, Sarada Saud, Tatjana Achmedov, Sebastian Süsser, Antonella Vera-Guapi, Konstantin Müller, Yves Matthess, Eva Quandt et al. · 2023 · Scientific Reports
38. Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation
    Kyle M. Ford, Brenton P. Munson, Samson H. Fong, Rebecca Panwala, Wai Keung Chu, Joseph Rainaldi, Nongluk Plongthongkum, Arunachalam Vinayagam, Jarek Kostrowicki, Dario Meluzzi et al. · 2023 · Scientific Reports
39. Large scale control and programming of gene expression using CRISPR
    Matthew Deyell, Sandeep Ameta, Philippe Nghe · 2019 · Seminars in Cell and Developmental Biology
40. CRISPR-Cas9-mediated loss-of-function screens
    Jiaqing Liu, Tao Li · 2019 · Frontiers in Life Science
41. Decoding directional genetic dependencies through orthogonal CRISPR/Cas screens
    Michael Boettcher, Ruilin Tian, James A Blau, Evan Markegard, David Wu, Anne Biton, Noah Zaitlen, Frank P. McCormick, Martin Kampmann, Michael T. McManus · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
42. Mapping in vivo genetic interactomics through Cpf1 crRNA array screening
    Ryan Dz-Wei Chow, Guangchuan Wang, Adan Codina, Lupeng Ye, Sidi Chen · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
43. A global genetic interaction map of a human cell reveals conserved principles of genetic networks
    Maximilian Billmann, Michael Costanzo, Xiang Zhang, Arshia Zernab Hassan, Mahfuzur Rahman, Kevin R. Brown, Katherine Chan, Amy H.Y. Tong, Carles Pons, Henry N. Ward et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
44. A unified genetic perturbation language for human cellular programming
    Austin Hartman, Oliver Takacsi-Nagy, Courtney Kernick, Nicole E. Theberath, Johnathan Lu, Lujing Wu, Michelle Mantilla, Siddhesh Mittra, Alison K. McClellan, Nicole Johnson et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
45. Applications of Genome-wide Screening of CRISPR/Cas9 Knockout Library in Identifying Novel Molecular Targets for Xenobiotics
    Simin Lang, Xueyang Lin, Shengran Wang, Weiqiang Sun, Yufeng Yang, Yang Chen, Zhenghao Bao, Wenya Feng, Yongan Wang, Yuan Luo · 2025 · Environment & Health
46. CRISPR libraries: A powerful screening tool for function and mechanism study of cancer
    Chengyu Jia, Zhengyan Liang, Xinyi Yao, Qiao Lin, Yin Zhang⋆ · 2025 · Cell investigation.
47. Integrative structure determination of histones H3 and H4 using genetic interactions
    Ignacia Echeverria, Hannes Braberg, Nevan J. Krogan, Andrej Šali · 2022 · FEBS Journal
48. A Yeast BiFC-Seq Method for Genome-Wide Interactome Mapping
    Limin Shang, Yuehui Zhang, Yuchen Liu, Chaozhi Jin, Yanzhi Yuan, Chunyan Tian, Ming Ni, Xiaochen Bo, Li Zhang, Dong Li et al. · 2021 · Genomics Proteomics & Bioinformatics
49. Genetically Encoded Fluorescence Barcodes Allow for Single-Cell Analysis via Spectral Flow Cytometry
    Xiaoming Lu, Daniel J. Pritko, Megan Abravanel, Jonah R. Huggins, Oluwaferanmi Ogunleye, Tirthankar Biswas, Katia C. Ashy, Semaj K. Woods, Mariclaire W.T. Livingston, Mark Blenner et al. · 2025 · ACS Synthetic Biology
50. CRISPR–Cas9 for Drug Discovery in Oncology
    Sylvie Mireille Guichard · 2017 · Annual reports in medicinal chemistry
51. The ability of transcription factors to differentially regulate gene expression is a crucial component of the mechanism underlying inversion, a frequently observed genetic interaction pattern
    Saman Amini, Annika Jacobsen, Olga Ivanova, Philip Lijnzaad, Jaap Heringa, Frank C. P. Holstege, K. Anton Feenstra, Patrick Kemmeren · 2019 · PLoS Computational Biology
52. Advancing CRISPR-Based Programmable Platforms beyond Genome Editing in Mammalian Cells
    Yasutomi Higashikuni, Timothy K. Lu · 2019 · ACS Synthetic Biology
53. Cutting down the time to identify challenging tumor therapeutic targets and drug combinations using synthetic lethal approaches
    John Stephen Lazo · 2018 · F1000Research
54. Shuffle-Seq: En masse combinatorial encoding for n -way genetic interaction screens
    Atray C. Dixit, Olena Kuksenko, David Feldman, Aviv Regev · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
55. Novel mosaic mice with diverse applications
    Yuxin Chen, Shaoshuai Mao, Bo Liu, Zhengyu Jing, Ying Zang, Jing Xia, Jianlong Sun, Tian H. Chi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
56. MiT4SL: multi-omics triplet representation learning for cancer cell line-adapted prediction of synthetic lethality
    Siyu Tao, Yimiao Feng, Yang Yang, Min Wu, Jie Zheng · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
57. CrossPlan: systematic planning of genetic crosses to validate mathematical models
    Aditya Pratapa, Neil R. Adames, Pavel Kraikivski, Nicholas Franzese, John J. Tyson, Jean Peccoud, T. M. Murali · 2018 · Bioinformatics
58. CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells
    Shan Jin, Hong Yong, Yousheng Liu, Wuyuntu Bao · 2023 · Advances in Medical Sciences
59. MPASL: multi-perspective learning knowledge graph attention network for synthetic lethality prediction in human cancer
    Ge Zhang, Yitong Chen, Chaokun Yan, Jianlin Wang, Wenjuan Liang, Junwei Luo, Huimin Luo · 2024 · Frontiers in Pharmacology
60. Automated Design of Oligopools and Rapid Analysis of Massively Parallel Barcoded Measurements
    Ayaan Hossain, Daniel P. Cetnar, Travis L. LaFleur, James R. McLellan, Howard M. Salis · 2024 · ACS Synthetic Biology
61. Evaluation of Cas13d as a tool for genetic interaction mapping
    Ghanem El Kassem, Jasmine Hillmer, Michael Boettcher · 2025 · Nature Communications
62. Incomplete paralog compensation generates selective dependency on TRA2A in cancer
    Amanda R. Lee, Anna Tangiyan, Isha Singh, Peter S. Choi · 2025 · PLoS Genetics
63. Reforming cotton genes: from elucidation of DNA structure to genome editing
    Muhammad Salman Mubarik, Sajid Majeed, Sultan Habibullah Khan, Xiongming Du, James Frelichowski, Lori Lynn Hinze, Muhammad Tehseen Azhar · 2021 · TURKISH JOURNAL OF AGRICULTURE AND FORESTRY
64. CRISPR screening in cancer stem cells
    Bei Wang, Alan S.L. Wong · 2022 · Essays in Biochemistry
65. Latent space feature representation on multiple biological network for synthetic lethality interaction prediction
    Jinxin Li, Xinguo Lu, Kaibao Jiang, Daoxu Tang, Fengxu Sun, Jingjing Ruan · 2023 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
66. SLAYER: a computational framework for identifying synthetic lethal interactions through integrated analysis of cancer dependencies
    Ziv Cohen, Ekaterina Petrenko, Alma Sophia Barisaac, Enas R. Abu‐Zhayia, Chen Yanovich-Ben-Uriel, Nabieh Ayoub, Dvir Aran · 2025 · NAR Genomics and Bioinformatics
67. G2G: A web-server for the prediction of human synthetic lethal interactions
    Yom Tov Almozlino, Iftah Peretz, Martin Kupiec, Roded Sharan · 2020 · Computational and Structural Biotechnology Journal
68. [Development and applications of CRISPR/Cas9 library screening technology in cancer research].
    Ting Lei, Bin Xiao, Yongyin He, Jing Tao Qu, Zhaohui Sun, Linhai Li · 2019 · Europe PMC (PubMed Central)
69. Elucidating the anti-cancer mechanisms for transition-state structure inhibitors of nucleoside phosphorylases methylthioadenosine-DADMe-immucillin A and forodesine
    Namal Coorey · 2017
70. Scaling perturbations: beyond genome-scale CRISPR screens
    Anran Tang, Rico Chandra Ardy, Rafaela Mendes, Thomas M. Norman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
71. Advancing inducible gene-inactivation systems to explore synthetic lethality
    Ádám Tamás Sánta, Alexandra Graf, Katalin Vincze-Kontár, Katalin Kovács, Bernadett Bóna, Mónika Mórocz, Ernö Kiss, Lajos Haracska · 2026 · NAR Cancer
72. CRISPR-based mapping of genetic interactions
    Ross Cloney · 2017 · Nature Reviews Genetics
73. Synthetic Lethality – Its Current Application and Potential in Oncological Treatment
    Lucie Bortlíková, Petr Müller, Bořivoj Vojtěšek, Vladimír Rak, Marek Svoboda · 2019 · Klinicka onkologie
74. PRODE recovers essential and context-essential genes through neighborhood-informed scores
    Thomas Cantore, Paola Gasperini, Riccardo Bevilacqua, Yari Ciani, Sanju Sinha, Eytan Ruppin, Francesca Demichelis · 2025 · Genome biology
75. RiboJ-assisted non-repeated sgRNA arrays for enhanced CRISPR multiplex genome engineering in Escherichia coli
    Seung‐Gyun Woo, Seong Keun Kim, Tae Hyun Kim, Subeen Kim, Youshin Kim, Seung‐Goo Lee, Dae‐Hee Lee · 2025 · Chemical Engineering Journal
76. PrePAIRing Cas9s for screening success
    Zhuo Long Zhou, Wensheng Wei · 2018 · Nature Biotechnology
77. NEM-Tar: A Probabilistic Graphical Model for Cancer Regulatory Network Inference and Prioritization of Potential Therapeutic Targets From Multi-Omics Data
    Yuchen Zhang, Lina Zhu, Xin Wang · 2021 · Frontiers in Genetics
78. Finding meaning in chaos: a selection signature for functional interactions and its use in molecular biology
    Lorin Weiner, Janice L. Brissette · 2022 · FEBS Journal
79. Theory for High-Throughput Genetic Interaction Screening
    Madeline E. McCarthy, William B. Dodd, Xiaoming Lu, Daniel J. Pritko, Nishi D. Patel, Charlotte V. Haskell, Hugo Sanabria, Mark Blenner, Marc R. Birtwistle · 2023 · ACS Synthetic Biology
80. Towards an Integrated Map of Genetic Interactions in Cancer Cells
    Benedikt Rauscher, Florian Heigwer, Luisa Henkel, Thomas Hielscher, Oksana Voloshanenko, Michael Boutros · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
81. Inducible, tunable and multiplex human gene regulation using CRISPR-Cpf1-based transcription factors
    Yu Gyoung Tak, Benjamin P. Kleinstiver, James K. Nuñez, Jonathan Y. Hsu, Jingyi Gong, Jonathan S. Weissman, J. Keith Joung · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
82. SpCas9 activity prediction by DeepSpCas9, a deep learning-based model with unparalleled generalization performance
    Hui Kwon Kim, Younggwang Kim, Sungtae Lee, Seonwoo Min, Jung Yoon Bae, Jae Woo Choi, Jinman Park, Dongmin Jung, Sungroh Yoon, Seokjoong Kim · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
83. Host cell factors important for BHV-1 cell entry revealed by genome-wide CRISPR knockout screen
    Wenfang Spring Tan, Enguang Rong, Inga R. Dry, Simon Geoffrey Lillico, Andy S Law, Bruce Whitelaw, Robert G. Dalziel · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
84. Reproducibility metrics for CRISPR screens
    Maximilian Billmann, Henry N. Ward, Michael Aregger, Michael Costanzo, Brenda Andrews, Charles M. Boone, Jason Moffat, Chad L. Myers · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
85. Cell context-specific Synthetic lethality Prediction and Mechanism Analysis
    Yucui Xing, Mengchen Pu, Kaiyang Cheng, Kai Tian, Lanying Wei, Weisheng Zheng, Gongxin Peng, Jielong Zhou, Yingsheng Zhang · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
86. Quantitative analysis of genetic interactions in human cells from genome-wide CRISPR-Cas9 screens
    Maximilian Billmann, Michael Costanzo, Mahfuzur Rahman, Katherine Chan, Amy H.Y. Tong, Henry N. Ward, Arshia Zernab Hassan, Xiang Zhang, Kevin R. Brown, Thomas Rohde et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
87. SL-Miner: a web server for mining evidence and prioritization of cancer-specific synthetic lethality
    Xin Liu, Jieni Hu, Jie Zheng · 2024 · Bioinformatics
88. Integrated systems biology approaches in chronic disease research
    Munichandra Babu Tirumalasetty, Mayank Choubey · 2025 · Elsevier eBooks
89. Complementary human gene interaction maps from radiation hybrids and CRISPRi
    Desmond J. Smith · 2025 · Physiological Genomics
90. Using genetic buffering relationships identified in fission yeast to reveal susceptibilities in cells lacking hamartin or tuberin function
    Ashyad Rayhan, Adam C. Faller, Ryan Chevalier, Alannah J.P. Mattice, Jim Karagiannis · 2017 · Biology Open
91. In vivo combinatorial knockout screens using CRISPR-Cpf1
    Sidi Chen, Ryan Dz-Wei Chow, Guangchuan Wang, Lupeng Ye, Sidi Chen · 2019 · Protocol Exchange
92. DSCN: Double-target selection guided by CRISPR screening and network
    Enze Liu, Xue Wu, Lei Wang, Yang Huo, Huanmei Wu, Lang Li, Lijun Cheng · 2022 · PLoS Computational Biology
93. Multi‐omics characterization of synthetic lethality‐related molecular features: implications for SL ‐based therapeutic target screening
    Shenghui Weng, Hang Ruan · 2022 · FEBS Journal
94. The declining insulinogenic index correlates with inflammation and metabolic dysregulation in non-obese individuals assessed by blood gene expression
    Alessandro Nasti, Miki Okumura, Yumie Takeshita, Tuyen Thuy Bich Ho, Yoshio Sakai, Takaaki Sato, Chiaki Nomura, Hisanori Goto, Yujiro Nakano, Takeshi Urabe et al. · 2024 · Diabetes Research and Clinical Practice
95. Gene Therapy and Gene Editing
    Niloofar Bazazzadegan, Mandana Hasanzad, Seyedeh Sedigheh Abedini · 2024 · Springer eBooks
96. Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do
    Tao Yin · 2021 · Precision Clinical Medicine
97. Unbiased identification of nanoparticle cell uptake mechanism via a genome-wide CRISPR/Cas9 knockout screen
    Eric L. Van Nostrand, Sarah A. Barnhill, Alexander A. Shishkin, David A. Nelles, Eric Byeon, Thai B. Nguyen, Yiu Chueng Eric Wong, Nathan C. Gianneschi, Gene Wei-Ming Yeo · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
98. Pooled CRISPR KO Screens for Target Identification
    Antje K. Grotz, Sumit Deswal · 2022 · Wiley eBooks
99. Minimized combinatorial CRISPR screens identify genetic interactions in autophagy
    Valentina Diehl · 2022
100. Enhanced methods for genetic assays in Drosophila cells
     Y Wang, JY Lee, Amy Housden, Emma Hottinger, Benjamin E. Housden · 2024 · bioRxiv (Cold Spring Harbor Laboratory)